Custom CAR-NK Manufacturing

Accelerate your novel cancer immunotherapy development by leveraging our cutting-edge CAR-NK manufacturing platform. As the most experienced CRO in the CAR-T cell industry, having developed over 60 types of CAR-T/NK cells and target cells in the last 5 years, we provide a complete and reliable service to drive your project forward.

  • Generate large numbers of cells with high purity.
  • Benefit from several patented innovations in CAR construct design.
  • Choose from mRNA electroporation or lentivirus transduction.
  • Supply your own monoclonal antibodies or leave development to us.

Choose ProMab for your CAR-NK manufacturing

With their efficient tumor-killing power, CAR-NK cells are a vital tool in the development of novel immunotherapies. We understand that you need access to quality cells-fast-when tackling cancers such as multiple myeloma, leukemia, and sarcoma. That’s why we developed our cutting-edge platform to generate large numbers of cells with high purity, arming you with the tools you need for your research.

Our platform, your cells

At ProMab, you can use our platform to generate customized cells to your own specifications. Our platform has 10 core components that can be configured for your own personalized needs for CAR-NK manufacturing. 

We can begin the process with a plan to include monoclonal antibody development or base the plan on your own existing antibody sequence to generate CAR constructs, giving you full control. Once the CAR constructs have been generated, you can choose between mRNA electroporation or lentivirus transduction as a delivery system to create your cells. To ensure that your cells are of the highest purity and quality, they undergo a range of functional assays and tuning, with continued optimization until they meet your project needs.

CAR-NK workflow showing lentivirus transduction.

CAR-NK PLATFORM ANTIBODY SCREENING

HYBRIDOMA SEQUENCING

mRNA TRANSFECTION

LENTIVIRUS PRODUCTION

CAR-NK  CELL PRODUCTION

RTCA & CYTOKINE ASSAY

AFFINITY TUNE-UP & HUMANIZATION

ANIMAL STUDIES

CAR-NK CELL EXPANSION & OPTIMIZATION

CAR construct plasmid

small_img1a_d424009dfb.png
img2a_a666c4b81daaa.png

Streamlining Your Preclinical and Clinical Development

Using our experience in CAR research, we are able to offer preclinical and clinical development studies as part of our CAR-NK service. Making use of our in-house vivarium and 2 GMP manufacturing facilities, we can take care of your CAR-NK discovery and development needs, whatever your project. 

We offer a development service that is tailored to you and your project, including options for licensing and partnering. Contact us to find out how we can streamline your preclinical and clinical development today.

Discovery Services Timelines

Accelerate your research timelines by making use of our comprehensive discovery services. We provide in vitro and in vivo offerings all within a single organization, making the process as simple as possible for you. With our end-to-end solution, you can tailor our discovery and development services to suit you, whatever your starting point.

aa1.svg

Develop Antibodies

Create mouse, rabbit, and human monoclonal antibodies using our validated antibody design and development platforms.

aa2.svg

Package Vectors

Innovate your cancer immunotherapies by packaging novel co-expression constructs and any generation of CAR domain into your vectors.

aa3.svg

Scale Production

Expand your research horizons with scalable CAR-NK cell production from our GMP manufacturing facilities.

aa4.svg

Ensure Quality

Get reliable CAR expression, cytokine release, and cytotoxicity measurements from our expert team with years of CAR immune cell experience.

Quality you can rely on

small_nkcellpurity1_a83f1e5088.png

NK cell purity is >80% on day 9 and >95% on day 14 of culture.

small_nkcellexpansion1_164c868604.png

NK cell numbers expand 35-fold on day 9 and 75-fold on day 14.

small_lenti1_c62fe88329.png

Human PBMC were transduced with lentivirus encoding the CAR; seven days later, gated NK cells were analyzed by flow cytometry for CAR expression.

small_electro2_fd1778475b.png

NK cells were generated from human PBMC, electroporated with CAR mRNA, and analyzed by flow cytometry for CAR expression 24 hours later.

Service plans and prices

To allow for either custom antibody creation or the use of your own antibody, we offer the following service plans and prices for CAR-NK manufacturing:

Plan A

Construct a CAR based on your antibody sequence construct from a mouse monoclonal antibody or fully human single-chain variable antibody fragment (scFv) from our existing library.

DEVELOPMENT STAGE DESCRIPTION Price
Phase I (optional) Immunization of Balb/C mice with recombinant protein or carrier-conjugated peptide. Generation of hybridoma cell lines following antibody validation against the correctly presented antigen. $6,995
Phase II (optional) Sequencing of the antibody's heavy and light chains. $1,800
Phase III Synthesis and cloning of an scFv with selected CAR domains into a lentivirus vector. Generation of 1x108 lentivirus viral particles. $7,000
Phase IV Transduction with lentivirus or electroporation with the CAR mRNA. FACS analysis to validate CAR expression in NK cells. $6,000 to 8,000
Phase V Measurement of CAR function: real-time cytotoxicity assay, quantitation of cytokine production (IFN-γ, IL-2, Granzyme B, GM-CSF). $7,000

Plan B

Generate the entire construct from a mouse monoclonal antibody or fully human single-chain variable antibody fragment (scFv) from our existing library.

DEVELOPMENT STAGE DESCRIPTION Price
Phase III

Synthesis and cloning of an scFv with selected CAR domains into a lentivirus vector. Generation of 1x10^8 lentivirus viral particles.

$6,000
Phase IV Transduction with lentivirus or electroporation with the CAR mRNA.  FACS analysis to validate CAR expression in NK cells. $6,000 to $8,000
Phase V Measurement of CAR function: real-time cytotoxicity assay, quantitation of cytokine production (IFN-γ, IL-2, Granzyme B, GM-CSF). $8,000
Phase V Tumor study in NSG/NOG mice. Starting at $15,000

Start manufacturing your cells today

We’ll take care of your CAR-NK manufacturing so that you can focus on insights and innovations. Together, we can change the way the world treats cancer.

5,000+

monoclonal antibodies generated

50+

filed patents

500+

CAR-T projects finished

4

Phase 2 clinical trials started

Featured Publications

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells.
Generation of CAR-T Cells for Cancer Immunotherapy.
CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth.

FAQs

What are CAR-NK cells?

Why choose CAR-NK cells over CAR-T cells?

What models do ProMab have to support my CAR-NK cell development?

Related Services

Custom Antibody Generation

Advance your antibody R&D with our well-established services designed by specialists with over 2 decades of experience generating highly specific and potent monoclonal antibodies.

Cell Line Engineering

Whether you need ‘ready-made’ or custom cell line development services, our experienced team is here to aid you in CAR-T, CAR-NK, CAR-Macrophage, engineered cell lines, and in vitro validation.

Super CAR-NK

This innovative service represents a significant leap forward from traditional CAR-NK therapies. At its core, Super CAR-NK is designed to enhance immunotherapeutic efficacy, providing an unprecedented level of target cell elimination.